All In Biotech

Drug Trial Radar · NCT03237845

Safety and Efficacy in Adult Subjects With Acute Migraines

BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine

Last checked: Nov 19, 2026Latest source record: Feb 16, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,499 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,499

Actual

Start

Jul 27, 2017

Primary completion

Jan 25, 2018

Study completion Jan 31, 2018

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Aug 3, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the efficacy of BHV-3000 (rimegepant) versus placebo in subjects with Acute Migraines

Conditions

  • Migraine, With or Without Aura

Interventions

  • RimegepantDrug

    75 mg tablet QD

  • PlaceboDrug

    Placebo tablet to match rimegepant dose QD

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Freedom From Pain at 2 Hours Post-doseTime frame: 2 Hours post-dose
  2. Percentage of Participants With Freedom From Most Bothersome Symptom (MBS) at 2 Hours Post-doseTime frame: 2 Hours

Locations

50 sites in 1 country. Site status is shown where the registry gives one.

  • Coastal Clinical Research

    Mobile, Alabama

  • Thunderbird Internal Medicine / Radiant Research, Inc.

    Glendale, Arizona

  • Woodland Research Northwest, LLC

    Rogers, Arkansas

  • eStudySite

    La Mesa, California

  • Collaborative Neuroscience Network, LLC

    Long Beach, California

  • Pharmacology Research Institute

    Los Alamitos, California

  • Pharmacology Research Institute

    Newport Beach, California

  • Pacific Research Partners LLC

    Oakland, California

  • National Research Institute

    Panorama City, California

  • California Neuroscience Research Medical Group, Inc.

    Sherman Oaks, California

  • Clinical Trials of the Rockies

    Denver, Colorado

  • AGA Clinical Trials

    Hialeah, Florida

  • Clinical Neuroscience Solutions

    Jacksonville, Florida

  • Renstar Medical Research

    Ocala, Florida

  • Clinical Neuroscience Solutions, Inc.

    Orlando, Florida

  • Meridien Research

    Tampa, Florida

  • Radiant Research, Inc.

    Atlanta, Georgia

  • Savannah Neurology Specialists

    Savannah, Georgia

  • Christie Clinic, LLC

    Champaign, Illinois

  • PMG Research of McFrland Clinic

    Ames, Iowa

  • Heartland Research Associates, LLC

    Augusta, Kansas

  • Heartland Research Associates, LLC

    Newton, Kansas

  • Heartland Research Associates, LLC

    Park City, Kansas

  • Heartland Research Associates, LLC

    Wichita, Kansas

  • Heartland Research Associates, LLC

    Wichita, Kansas

  • MedPharmics, LLC

    Metairie, Louisiana

  • NECCR Primacare Research, LLC

    Fall River, Massachusetts

  • Albuquerque Neuroscience, Inc.

    Albuquerque, New Mexico

  • Radiant Research, Inc.

    Jamaica, New York

  • PMG Research of Raleigh, Inc.

    Raleigh, North Carolina

  • Wake Research Associates, LLC

    Raleigh, North Carolina

  • PMG Research of Wilmington, LLC

    Wilmington, North Carolina

  • Radiant Research, Inc.

    Cincinnati, Ohio

  • Radiant Research, Inc.

    Columbus, Ohio

  • Midwest Clinical Research Center

    Dayton, Ohio

  • Neurology Diagnostics, Inc.

    Dayton, Ohio

  • Aventiv Research, Inc.

    Dublin, Ohio

  • Summit Research Network (Oregon), Inc.

    Portland, Oregon

  • Oregon Center for Clinical Investigations, Inc

    Salem, Oregon

  • Fieve Clinical Research, Inc.

    Scranton, Pennsylvania

Showing 40 of 50 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.